Delivery Order SPE2DB25D3012-SPE2DB26FWVVH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This is a firm fixed price delivery order with a ceiling value of $17,220.22 and an ultimate completion date of September 17, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating it was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,611.11 by the Defense Logistics Agency on October 29, 2025, for the supply of Synvisc-One Syringe 6ML. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 30, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This delivery order, awarded on October 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $2,729.52 in firm fixed price compensation for the supply of SYNVISC-One Syringe 6ML, a pharmaceutical product for joint pain and osteoarthritis treatment. The contract is a non-set-aside award, reflecting open competition, and is scheduled for ultimate completion by October 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,942.56 delivery order on July 29, 2025, for Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a medical device used for joint pain management, valued at $1,707.89. This competitively awarded, firm fixed price delivery order was issued on May 1, 2025, with an ultimate completion date of May 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a $58,094.55 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Synvisc-One syringes (6ML, 1 unit). The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. This...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVVHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,194.04 on November 6, 2025, for the supply of Synvisc-One Syringe 6ML, a viscosupplementation medication used in joint pain management. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen Drug Corp's extensive pharmaceutical supply portfolio supporting federal medical procurement needs, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor and critical vendor for DLA's medical supply chain, AmerisourceBergen holds a significant $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 11/6/25 |